|
|
||||||||
1 Departments of Physiology and Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267; 3 College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612; and 2 Dermatology Division, Department of Medicine, University of California at Los Angeles, Los Angeles, California 90095
| |
ABSTRACT |
|---|
|
|
|---|
We used a reconstituted fiber formed when 3T3 fibroblasts are grown in collagen to characterize nonmuscle contractility and Ca2+ signaling. Calf serum (CS) and thrombin elicited reversible contractures repeatable for >8 h. CS elicited dose-dependent increases in isometric force; 30% produced the largest forces of 106 ± 12 µN (n = 30), which is estimated to be 0.5 mN/mm2 cell cross-sectional area. Half times for contraction and relaxation were 4.7 ± 0.3 and 3.1 ± 0.3 min at 37°C. With imposition of constant shortening velocities, force declined with time, yielding time-dependent force-velocity relations. Forces at 5 s fit the hyperbolic Hill equation; maximum velocity (Vmax) was 0.035 ± 0.002 Lo/s. Compliance averaged 0.0076 ± 0.0006 Lo/Fo. Disruption of microtubules with nocodazole in a CS-contracted fiber had no net effects on force, Vmax, or stiffness; force increased in 8, but decreased in 13, fibers. Nocodazole did not affect baseline intracellular Ca2+ concentration ([Ca2+]i) but reduced (~30%) the [Ca2+]i response to CS. The force after nocodazole treatment was the primary determinant of stiffness and Vmax, suggesting that microtubules were not a major component of fiber internal mechanical resistance. Cytochalasin D had major inhibitory effects on all contractile parameters measured but little effect on [Ca2+]i.
cytochalasin D; nocodazole; nonmuscle mechanics; Swiss 3T3; tensegrity; intracellular calcium concentration
| |
INTRODUCTION |
|---|
|
|
|---|
THE ROLE OF CYTOSKELETAL FILAMENT networks in modulating nonmuscle contractility is unclear. Giuliano and colleagues (7) have proposed that nonmuscle contractility is regulated both by modulating the activity of molecular motors, such as myosin II, and by altering the cytomatrix in such a manner as to either resist or yield to the tension applied by the motors. This hypothesis is supported by the observation that tension increases in response to disruption of microtubules by nocodazole (5) in cultured fibroblasts (4) and reconstituted fibroblast fibers (21). These data are also consistent with the view that microtubules provide some form of internal resistance. In tensegrity models (6), a portion of a cell's contractile force is borne by rigid internal structures, reducing the force transmitted to external structures, as monitored by force transducers. Alternatively, other mechanisms may underlie the effects of nocodazole. For example, the increase in smooth muscle contractility elicited by nocodazole has been correlated with an increase in intracellular Ca2+ concentration ([Ca2+]i) (17).
If microtubules constitute an internal resistance in parallel with the actin-myosin network and are capable of bearing compressive forces, depolymerization of microtubules should result in a greater measured force as the load shifts from internal microtubule structures to the external force transducer. One would also expect that other mechanical parameters, such as cell mechanical stiffness and shortening velocity, would be sensitive to the presence of an intracellular mechanical resistance as that postulated for microtubules. In fact, on theoretical grounds, one might anticipate that the maximum shortening velocity (Vmax) would be particularly sensitive to intracellular resistances.
With the use of similar arguments, the effects of microfilament assembly in fibroblast contractility could also be deduced by studying the mechanical effects of cytochalasin D, known to disrupt microfilaments (3).
In this study, we developed a reconstituted fibroblast fiber, based on previous models (19, 21), that enables not only force to be quantitated but also velocity and stiffness in nonmuscle cells. We report that disruption of microfilaments has a profound effect on fibroblast contractility but not [Ca2+]i. Our detailed mechanical analysis, in contrast to hypotheses based on measurement of isometric force alone, does not support a role for microtubule resistance in the mechanical properties of reconstituted fibroblast fibers.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture and reconstitution of fibroblast into fibers. Swiss 3T3 fibroblast cells (passages 15-30) were cultured in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal calf serum (CS) and antibiotic-antimycotic (Ab/Am; 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B) at 37°C in a humidified, 5% CO2-95% O2 atmosphere. Fibroblast fibers were formed by growing 3T3 fibroblasts in rat tail collagen (Upstate Biotechnology, Lake Placid, NY) gel matrix by a modification of the method of Kolodney and Wysolmerski (21). Dispersed cells were suspended in an ice-cold collagen solution that contained 2 × 106 cells/ml and 0.5 mg/ml rat tail collagen in DMEM + 10% CS with added Ab/Am (Sigma). An aliquot (2 ml) of the collagen/cell suspension was poured into a well (0.8 × 5 cm × 0.5 cm deep) cut in a layer of silicone rubber in 100-mm glass petri dishes and placed in a CO2 incubator at 37°C. After 8 h, an additional 1 ml of DMEM + 10% CS and Ab/Am were added to each well. The preparations were incubated for 3-5 days or until the cells shrank the gel and formed a fiber. Except where noted, cells were placed in serum-free media the night preceding the day on which experiments were conducted.
Mechanics measurements. The fibers made from 3T3 fibroblasts were cut into 5-mm pieces and mounted between glass posts with a cyanoacrylate glue. One post was fixed and the other connected to an AME 801 silicon strain gage (SensoNor) force transducer. The fibers were bathed in physiological salt solution (MOPS-PSS) that contained (in mM): 140 NaCl, 4.7 KCl, 1.2 NaH2PO4, 0.02 EDTA, 1.2 MgSO4, 2.5 CaCl2, 5.5 dextrose, and 20 MOPS, pH 7.4, at 37°C.
For measurement of shortening velocity and stiffness, fibers (5-mm) were glued between the force transducer and a lever arm of which its position, and therefore the length of fiber, was controlled by a Cambridge Technology (Cambridge, MA) ergometer. Force-velocity relations were measured by imposing constant shortening velocities on the fiber, and measurement of the subsequent force. A series of eight different velocities at 60-s intervals was used for measurement of each individual force-velocity relation. Force-velocity data were fitted with the Hill equation, (F + a) · (V + b) = b · (Fo + a), using a nonlinear least-squares routine (Origin). Vmax was taken as the velocity at zero force. Stiffness was measured by imposition of rapid (<1 ms) shortening and stretching steps (
2.6 to
+0.6% Lo). A series of eight step changes at 60-s
intervals constituted an experimental set for the measurement of stiffness.
Measurement of the [Ca2+]i. Measurements of [Ca2+]i levels were obtained from cells loaded with the Ca2+-sensitive fluorescent dye, fura 2, based on the techniques of Grynkiewicz et al. (10). The fibroblast fibers were loaded with fura 2-AM. Fura 2-AM was prepared as a stock solution of 1 mM dye in DMSO. The fura 2 loading solution contained 3 µM fura 2-AM, 0.015% Pluronic F-127, and 0.5% DMSO in MOPS-PSS buffer. To aid in dispersion of the fura 2-AM, the loading solution was well sonicated. Fibroblast fibers were placed in this solution at room temperature for 3 h. After this loading period, fibroblasts were washed in MOPS-PSS buffer for 20 min to remove any unesterified dye.
A segment of fura 2-loaded fibroblast fiber was placed in a glass bottom culture dish and covered with nylon mesh to maintain isometric conditions. The fiber chamber had a total volume of 500 µl, which was perfused (5 ml/min) with the MOPS-PSS, to maintain a temperature of 37°C. [Ca2+]i was measured with an Intracellular Imaging (Cincinnati, OH) microscope-based system (InCa system). This fibroblast chamber was placed on a Nikon Diaphot inverted microscope with a fluorphase objective. Fluorescent images of cells excited at 340 and 380 nm and emitted at 510 nm were obtained with a Dage silicon-intensified target camera. After subtraction of background fluorescence, the 340 and 380 nm images were ratioed on a pixel by pixel basis, and the ratios converted to [Ca2+]i using a standard curve. Solutions containing known concentrations of free Ca2+ (Molecular Probes) were used to generate this standard curve. Fluorescence intensity was measured in 150 µl for each standard solution (0, 0.065, 0.100, 0.225, 0.351, and 0.602 µM free Ca2+ concentration) containing 13.3 µg/ml fura 2 pentapotassium salt. Quantitative analysis of the average subcellular Ca2+ was performed by defining the outline of the cell, summing the Ca2+ in all the pixels within the defined area, and dividing by the number of pixels.Confocal fluorescence microscopy. For phalloidin staining, fibers were fixed with 4% paraformaldehyde and embedded in 17% gelatin. Sections were cut at 100 µm using a Leica VT 1000 vibrating blade microtome and stained with rhodamine-conjugated phalloidin (Sigma, St. Louis, MO). Images were constructed from optical sections acquired by scanning confocal microscopy.
For microtubule staining, fibers were fixed with 4% paraformaldehyde, and 100-µm sections were cut with a Leica VT 1000 vibrating blade microtome. Sections were blocked with 5% goat serum and incubated overnight in a 1:100 dilution of monoclonal antibody to
-tubulin
(Amersham) followed by FITC-conjugated goat anti-mouse (Zymed, San
Francisco, CA) at 1:50. Images were acquired with an Olympus
epifluorescence microscope equipped with a high-resolution charge-coupled device camera.
Data analysis. All data are presented as means ± SE. Control and serum data were pooled and include some data previously reported (23). To assess the effects of cytochalasin D and nocodazole, a control contraction was elicited by 30% serum and the mechanical parameters were measured. After treatment with the drugs, the mechanical parameters were again measured. Paired comparisons, with each fiber serving as its own control, were made to control for variability among fibers. Differences were analyzed with paired t-tests; differences with a P value <0.05 were accepted as statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Structure of artificial fibers.
The formation of a fiber generally takes 3 days after the cell/collagen
suspension is poured into the mold. This transformation is shown in
Fig. 1. The final fiber has
dimensions of ~40 mm long and 1-2 mm diameter. For contractility
measurements, each fiber was cut into smaller segments (~5 mm). These
segments are about one-eighth of the whole fiber and would, if
proportional, contain ~5 × 105 of the original
cells. Histological analysis of sections indicated that the cells were
generally aligned along the long axis of the fiber. A more detailed
structural analysis of these types of fibers at both aggregate and
intracellular levels has been reported (21).
|
Isometric contraction.
Fibers were mounted under isometric conditions, then the length was
increased to match the original fiber length in the mold. After stress
relaxation, force attained a baseline level of 53.0 ± 0.003 µN
(n = 30). Addition of serum increased isometric force that returned to prestimulus levels on washout (Fig.
2). These contraction/relaxation cycles
could be repeated for at least 8 h, though over prolonged periods
some stress relaxation in baseline force was noted. We could not
determine a length dependence of force generation as classically done
for striated muscle (9) because these preparations did not
sustain stable forces when lengthened beyond the length formed in the
mold. If untethered, the fibers shortened to approximately one-third
the original formed length. Thus, at shorter lengths, the force would
decrease. Serum induced dose-dependent contractions (Fig.
3), and a maximum isometric force of
106 ± 12 µN (n = 30) was developed in response
to 30% serum. The times to half-maximal contraction and relaxation
were 4.7 ± 0.3 and 3.1 ± 0.3 min (n = 22),
respectively. Thrombin (2 U/ml) also elicited an increase in force,
averaging 19.0 ± 2.0 µN (n = 13) above the
prestimulus baseline.
|
|
|
Force-velocity relations.
These relations were studied by imposing a series of constant speed
decreases in length and measurement of the consequent force responses.
Figure 5A shows a typical
experimental record for a single fiber composed of individual force
responses to eight imposed shortenings of varying speeds. Force can be
seen to continuously decline with the duration of shortening, similar
to behavior reported for rat aorta (22) and hog coronary
artery (17). Thus there is a family of force-velocity
relations (Fig. 5B), each corresponding to the point in time
at which the force values were measured. In the inset to Fig.
5B, Vmax taken from each Hill
equation was plotted as a function of the point in time at which the
forces were measured. Vmax decreases rapidly at
first, then is relatively stable between 3 and 5 s. The velocities
measured at early time points may in fact include discharge of series
mechanical compliances, before a quasisteady state is
achieved. In subsequent experiments, the force at 5 s was
taken for all force-velocity relations. This point in time was chosen
as it provided the widest range of measurable values over the differing
experimental conditions. This provides a means for determining an
operational, relative Vmax for comparison of the
different conditions.
|
Fiber stiffness.
Stiffness was measured by imposition of rapid (<1 ms) step changes in
length. Typical responses are shown in Fig.
6A. After imposition of the
step, the force response exhibited a peak value followed by stress
relaxation. A plot of the peak force responses against the imposed step
length change is shown in Fig. 6B. Typical of muscle
behavior, the fibroblast peak force responses were linear in the region
where stretches were imposed, and this linear range extended to short
step decreases. In the serum-stimulated fibers, the slope of the linear
relation between force and length (stiffness) was 23.4 ± 0.92 mN/Lo (n = 30). Extrapolation of the linear
portion gives an intercept on the length axis of
0.0076 ± 0.0006
L/Lo (n = 30); i.e., a step of
0.76% Lo is required to discharge the maximum isometric
force. This value is lower than isolated smooth muscle cells
(28) but comparable to that reported for skinned smooth
muscle fibers (2).
|
Effects of nocodazole and cytochalasin D on ultrastructure and
mechanical parameters of reconstituted fibroblast fibers.
We used fluorescence microscopy to verify the ability of cytochalasin D
and nocodazole to disrupt microfilaments and microtubules in these
preparations, respectively. We selected concentrations based on the
reported disruption of microtubules and actin filaments in cultured
fibroblasts (21). As illustrated in Fig.
7A, intact microtubules were
clearly visible in cells populating control fibers, whereas cells from
fibers treated with 10 µM nocodazole for 10 min (Fig. 7B)
exhibited a diffuse distribution of tubulin, indicating
depolymerization of microtubules.
|
|
|
|
|
|
Effects of nocodazole and cytochalasin D on
[Ca2+]i.
To further delineate the mechanisms underlying the effects of
microtubule or microfilament disruption on contractility, we measured
[Ca2+]i using ratiometric fluorescence
spectroscopy and the Ca2+-sensitive dye fura 2. Nocodazole
(10 µM) elicited a small increase in force with little effect on
[Ca2+]i (Fig.
12). Addition of serum produced a
transient increase in [Ca2+]i that was
smaller (72.1% ± 3.8, n = 8, P = 0.002) than that seen in the absence of nocodazole. The addition of
serum in the presence of nocodazole elicited a force response that was
nearly identical (97.4% ± 0.9, n = 8, P = 0.02) to that in its absence.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
We have shown that artificial fibers composed of fibroblasts grown in a culture media including collagen provide a unique model for measurement of mechanical parameters in nonmuscle cells. Because cytochalasin D nearly abolishes mechanical responses, these mechanical parameters reflect aggregate cellular properties rather than those of the collagen matrix in which the cells are grown. In the absence of cells, collagen alone does not form fibers or support mechanical loads.
The aggregated cells generate force under unstimulated conditions. This is demonstrated by the ability of the fiber to shorten and by the inhibition of force by cytochalasin D. Both serum and thrombin elicit dose-dependent increases in isometric force. The response to serum of these Swiss fibroblasts was approximately fivefold greater than thrombin. The maximum isometric forces measured in this study were on the order of 150 µN. If one assumes that the original 4 × 106 fibroblasts were evenly distributed throughout the reconstituted fiber, and were 100 µm long with a 10-µm diameter, then the cellular cross-sectional area of the fiber can be calculated as ~0.8 mm2. The actual fiber cross-sectional area is difficult to determine exactly but is roughly between 1 and 4 mm2. Thus this estimate is not unrealistic and is comparable to some vascular smooth muscle tissue in which smooth muscle cells account for 25% of the vessel wall. Thus force per cellular cross-sectional area would be 0.2 mN/mm2. This is considerably less than that for smooth muscle, in which tissue values range from 10 to 200 mN/mm2, and potentially larger when translated to smooth muscle cellular cross-sectional areas. However, our calculated value of 0.2 mN/mm2 is of similar magnitude to those estimated for fibroblasts from wound contraction models in skin preparations (15).
Hyperbolic force-velocity relations, similar to tonic smooth muscle,
were observed in these reconstituted fibers. As force continuously
declined with time during the imposed constant shortening, assignment
of a maximum velocity depended on the time of measurement. This is
similar to that observed in studies of smooth muscle, in which, for
example, unloaded velocities showed a similar slowing with time.
Whether this is due to some internal resistance, as suggested for
smooth muscle (12), or a possible dependence on length
(11), is not known. However, the maximum velocities
deduced from these force-velocity relations were similar to those
visually measured in unloaded chicken embryo fibroblasts cells
on cutting from the naturally occurring constraints in the forming
molds (21). These maximum velocities are much slower than
striated muscle but similar to those reported for the slower, tonic
smooth muscles, such as the aorta (25). Velocity and
myosin ATPase activities are generally correlated. The low velocity of
these fibroblast fibers is consistent with the low-myosin
ATPase rates reported for nonmuscle myosin. The actin-activated
Mg2+-ATPase reported for clonal mouse
fibroblast myosin is 90 nmol · min
1 · mg
1
(1). This can be compared with 89 nmol · min
1 · mg
1 for
platelet myosin and 51 nmol · min
1 · mg
1 reported
for gizzard smooth muscle measured under similar conditions (26).
In assessment of the data as a whole, the level of isometric force appeared to be the major determinant of the speed of shortening. In Fig. 10, the maximum velocities under the various conditions studied were plotted against the level of isometric force. Whether the variations in force were due to the natural variations in response to serum or modified by nocodazole or cytochalasin D, higher levels of force were strongly correlated with higher velocities.
Fibroblast fiber stiffness was also assessed in this model and was found to be similar to that reported for smooth muscle cells but considerably higher than that for isolated smooth muscle tissue. This may reflect the differences in structures through which force is transmitted. Stiffness was related to the level of isometric force (Fig. 11), though this dependence was not as highly correlated as Vmax and was sharply reduced after cytochalasin D treatment. The relations between stiffness and force were similar for serum contractures in the presence or absence of nocodazole, which suggest that microtubules are not a major determinant of this parameter. The linear dependence of stiffness on force of these cell aggregates is similar to that observed for individual cells and predicted by tensegrity models (27).
We tested whether microtubules constituted significant mechanical resistance or internal load by measuring the effects of nocodazole, an agent known to disrupt microtubules (16), on shortening velocity and stiffness. Our immunomicroscopy confirmed that nocodazole at 10 µM also disrupted microtubule structures in fibroblasts in our reconstituted fibers (Fig. 7). Nocodazole has been shown in previous studies to increase isometric force in stimulated fibroblast fibers (21) that would be consistent with a reduction in internal resistance opposing the force generated by actin-myosin motors. In contrast to previous studies, we did not consistently observe an increase in force in response to nocodazole (Fig. 9A). However, in our studies, nocodazole was added to cells previously contracted with CS. Contraction with CS sharply decreased the additional response to nocodazole in chicken embryo fibroblasts (18). This finding suggests that, in contrast to the predictions of the tensegrity model, nocodazole and CS may cause contraction through a common signaling pathway that may become saturated by CS, thereby diminishing the nocodazole response.
Vmax would be expected to be very sensitive to such an internal resistance. Based on the measured force-velocity relations (Fig. 5B), eliminating an internal load with a magnitude of only 20% of the maximum isometric force would increase fiber Vmax by 40%. The effects of nocodazole on Vmax depended on its effects on force, which were variable. However, there was no net effect of nocodazole on Vmax of serum-stimulated fibers (Table 1).
The relation between the level of isometric force and Vmax seen after nocodazole treatment was also similar to that observed for serum stimulation alone (Fig. 10). This provides evidence against the presence of a specific mechanical resistance that can be attributed to microtubules. This is further supported by the effects of nocodazole on fiber stiffness. When nocodazole treatment was associated with increased force, stiffness increased. This is the opposite to expectation if disruption of microtubules removed an internal resistance. The increase may be attributed to more actin-myosin cross bridges under these conditions. This is consistent with recent studies suggesting that nocodazole treatment increases myosin light chain phosphorylation in fibroblasts (18).
The effects of nocodazole on both stiffness and Vmax appear to be mediated through its effects on force. Larger forces, independent of how they were generated, were associated with greater Vmax. This would be consistent with some type of nonmicrotubule internal resistance in the aggregated cell fiber. If such a resistance was constant, higher forces would lead to relatively less loading and faster velocities. This would also be consistent with the decrease in shortening velocity with time, as has been proposed for smooth muscle cells (12).
In contrast to nocodazole, cytochalasin D, which disrupts actin filaments (3), had dramatic inhibitory effects on the mechanical process(es) underlying all measured parameters. The effects of cytochalasin D on these mechanical parameters was paralleled by its depolymerization of actin filaments in the fibroblast fiber (Fig. 8). Thus the ability to develop force and to shorten is highly dependent on the integrity of the actin filament network. The decreases in both stiffness and Vmax by cytochalasin D were parallel to that of its inhibition of force and consistent with force being the primary determinant of these parameters. This would be consistent with actin-myosin interaction being the primary locus of force generation in these fibers.
It is also of interest to consider the possibility of linkage between actin microfilaments and microtubules, as suggested by actin binding properties of some microtubule-associated proteins (8, 14). If, by some manner, actin and microtubule networks are linked, and nocodazole destroys the linkage decreasing parallel cross bridges, then force, as well as stiffness, would be expected to decrease. This is what is observed. If these cross bridges are "lost" to force generation, then this may underlie the loss of force with nocodazole observed in some cases. On the other hand, if the loss of parallel cross bridges is translated into more series cross bridges, then one might anticipate Vmax to increase, which was not observed. Further speculation in lieu of high-resolution ultrastructure studies is not warranted. However, these mechanical data provide the first insight into the relations between force, stiffness, and shortening velocity in a nonmuscle contractile system.
Because cytochalasin D and nocodazole appear to be mediated via their effect on force, it was of interest to assess their effects on [Ca2+]i. The mechanism of activation of nonmuscle myosin is controversial (20, 23), but [Ca2+]i is likely a key second messenger. Treatment with nocodazole reduced the increase in [Ca2+]i in response to serum by ~30%, but had little effect on the developed force. Cytochalasin D, which dramatically reduced force, had an even lesser effect than nocodazole on the Ca2+ response to serum. Thus it is unlikely that the effects of either were mediated primarily through effects on [Ca2+]i.
In summary, reconstituted fibers formed by fibroblasts cultured in a collagen gel can be used for precise mechanical measurements in aggregated nonmuscle cells. Although the isometric force generated by these reconstituted fibers is significantly lower, maximum velocity and compliance are similar to that of smooth muscle fibers. In terms of the contractile response to serum, actin microfilaments play a major role in the mechanical properties of the reconstituted fibers, as might be expected for a myosin motor-driven system. Microtubules do not make a major contribution to an internal mechanical resistance or load against which the myosin system has been proposed to operate (7). Because the composition of the major components in these cultured cells can be readily manipulated by genetic techniques (23), this model system may provide a unique approach to the understanding of contractile mechanisms in nonmuscle as well as cultured muscle cells.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: R. J. Paul, Dept. of Molecular and Cellular Physiology, Univ. of Cincinnati College of Medicine, Cincinnati, OH 45267-0576 (E-mail: Richard.Paul{at}uc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 6 December 1999; accepted in final form 23 March 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adelstein, RS,
Conti MA,
Johnson GS,
Pastan I,
and
Pollard TD.
Isolation and characterization of myosin from cloned mouse fibroblasts.
Proc Natl Acad Sci USA
69:
3693-3697,
1972
2.
Arheden, H,
and
Hellstrand P.
Force response to rapid length change during contraction and rigor in skinned smooth muscle of guinea-pig taenia coli.
J Physiol (Lond)
442:
601-630,
1991
3.
Cooper, JA.
Effects of cytochalasin and phalloidin on actin.
J Cell Biol
105:
1473-1478,
1987
4.
Danowski, BA.
Fibroblast contractility and actin organization are stimulated by microtubule inhibitors.
J Cell Sci
93:
255-266,
1989
5.
DeBrabander, M,
and
DeMey J
(Editors).
Microtubules and Microtubule Inhibitors. Amsterdam: Elsevier, 1985.
6.
Dennerll, TJ,
Joshi HC,
Steel VL,
Buxbaum RE,
and
Heidemann SR.
Tension and compression in the cytoskeleton of PC-12 neurites. II. Quantitative measurements.
J Cell Biol
107:
665-674,
1988
7.
Giuliano, KA,
Kolega J,
DeBiasio RL,
and
Taylor DL.
Myosin II phosphorylation and the dynamics of stress fibers in serum-deprived and stimulated fibroblasts.
Mol Biol Cell
3:
1037-1048,
1992[Abstract].
8.
Gonzalez, M,
Cambiazo V,
and
Maccioni RB.
The interaction of Mip-90 with microtubules and actin filaments in human fibroblasts.
Exp Cell Res
239:
243-253,
1998[Web of Science][Medline].
9.
Gordon, AM,
Huxley AF,
and
Julian FJ.
The variation in isometric tension with sarcomere length in vertebrate muscle fibres.
J Physiol (Lond)
184:
170-192,
1966
10.
Grynkiewicz, G,
Poenie M,
and
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
11.
Gunst, SJ.
Effect of length history on contractile behavior of canine tracheal smooth muscle.
Am J Physiol Cell Physiol
250:
C146-C154,
1986
12.
Harris, DE,
and
Warshaw DM.
Slowing of velocity during isotonic shortening in single isolated smooth muscle cells. Evidence for an internal load.
J Gen Physiol
96:
581-601,
1990
13.
Hellstrand, P,
and
Johansson B.
Analysis of the length response to a force step in smooth muscle from rabbit urinary bladder.
Acta Physiol Scand
106:
221-238,
1979[Web of Science][Medline].
14.
Henrquez, JP,
Cross D,
Vial C,
and
Maccioni RB.
Subpopulations of
interact with microtubules and actin filaments in various cell types.
Cell Biochem Funct
13:
239-250,
1995[Web of Science][Medline].
15.
Higton, DIR,
and
James DW.
The force of contraction of full-thickness wounds of rabbit skin.
Br J Surg
51:
462-466,
1964.
16.
Jordan, MA,
and
Wilson L.
Use of drugs to study role of microtubule assembly dynamics in living cells.
Methods Enzymol
298:
252-276,
1998[Web of Science][Medline].
18.
Kolodney, MS,
and
Elson EL.
Contraction due to microtubule disruption is associated with increased phosphorylation of myosin regulatory light chain.
Proc Natl Acad Sci USA
92:
10252-10256,
1995
19.
Kolodney, MS,
and
Elson EL.
Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts.
J Biol Chem
268:
23850-23855,
1993
20.
Kolodney, MS,
Thimgan MS,
Honda HM,
Tsai G,
and
Yee HF, Jr.
Ca2+-independent myosin II phosphorylation and contraction in chicken embryo fibroblasts.
J Physiol (Lond)
515:
87-92,
1999
21.
Kolodney, MS,
and
Wysolmerski RB.
Isometric contraction by fibroblasts and endothelial cells in tissue culture: a quantitative study.
J Cell Biol
117:
73-82,
1992
22.
McMahon, EG,
Martin AF,
and
Paul RJ.
Isomyosins and mechanics in aortas from aldosterone salt hypertensive rats (Abstract).
Fed Proc
46:
1098,
1987.
23.
Obara, K,
Nikcevic G,
Pestic L,
Nowak G,
Lorimer DD,
Guerriero V, Jr,
Elson EL,
Paul RJ,
and
de Lanerolle P.
Fibroblast contractility without an increase in basal myosin light chain phosphorylation in wild type cells and cells expressing the catalytic domain of myosin light chain kinase.
J Biol Chem
270:
18734-18737,
1995
24.
Paul, RJ.
The chemical energetics of vascular smooth muscle. Intermediary metabolism and its relation to contractility.
In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am. Physiol. Soc, 1980, sect. 2, vol. II, chapt. 9, p. 201-235.
25.
Paul, RJ.
Smooth muscle: Mechanochemical Energy Conversion, Relations Between Metabolism and Contractility.
In: Physiology of the Gastrointestinal Tract (2nd ed.), edited by Johnson LR.. New York: Raven, 1987, p. 483-506.
25a.
Paul RJ, Bowman PS, and Kolodney MS. Effects of microtubule
disruption on force, velocity, stiffness, and
[Ca2+]i in porcine coronary artery. Am
J Physiol Heart Circ Physiol. In press.
26.
Sellers, JR,
Pato MD,
and
Adelstein RS.
Reversible phosphorylation of smooth muscle myosin, heavy meromyosin, and platelet myosin.
J Biol Chem
256:
13137-13142,
1981
27.
Wang, N,
Butler JP,
and
Ingber DE.
Mechanotransduction across the cell surface and through the cytoskeleton.
Science
260:
1124-1127,
1993
28.
Warshaw, DM,
and
Fay FS.
Cross-bridge elasticity in single smooth muscle cells.
J Gen Physiol
82:
157-199,
1983
This article has been cited by other articles:
![]() |
H. H. Wang, H. Tanaka, X. Qin, T. Zhao, L.-H. Ye, T. Okagaki, T. Katayama, A. Nakamura, R. Ishikawa, S. E. Thatcher, et al. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2060 - H2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nobe, K. Nobe, and R. J. Paul Fibroblast fiber contraction: role of C and Rho kinase in activation by thromboxane A2 Am J Physiol Cell Physiol, December 1, 2003; 285(6): C1411 - C1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Ingber Tensegrity I. Cell structure and hierarchical systems biology J. Cell Sci., April 1, 2003; 116(7): 1157 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Seasholtz The RHOad less traveled: the myosin phosphorylation-independent path from Rho kinase to cell contraction. : Focus on "Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation" Am J Physiol Cell Physiol, March 1, 2003; 284(3): C596 - C598. [Full Text] [PDF] |
||||
![]() |
H. Nobe, K. Nobe, F. Fazal, P. de Lanerolle, and R. J. Paul Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation Am J Physiol Cell Physiol, March 1, 2003; 284(3): C599 - C606. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |